SpringWorks Therapeutics Inc (SWTX)
36.80
+0.25
(+0.68%)
USD |
NASDAQ |
Nov 15, 12:13
SpringWorks Therapeutics Cash from Investing (Quarterly): 0.289M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.289M |
| March 31, 2024 | 21.46M |
| December 31, 2023 | -159.20M |
| September 30, 2023 | 34.60M |
| June 30, 2023 | 60.76M |
| March 31, 2023 | 98.60M |
| December 31, 2022 | -355.01M |
| September 30, 2022 | 86.23M |
| June 30, 2022 | 26.76M |
| March 31, 2022 | 26.42M |
| December 31, 2021 | 56.18M |
| Date | Value |
|---|---|
| September 30, 2021 | 35.78M |
| June 30, 2021 | 22.54M |
| March 31, 2021 | -30.92M |
| December 31, 2020 | -222.78M |
| September 30, 2020 | -127.56M |
| June 30, 2020 | -68.33M |
| March 31, 2020 | -0.16M |
| December 31, 2019 | -0.13M |
| September 30, 2019 | -0.084M |
| June 30, 2019 | -3.785M |
| March 31, 2019 | -0.261M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-355.01M
Minimum
Dec 2022
98.60M
Maximum
Mar 2023
-26.02M
Average
21.46M
Median
Mar 2024
Cash from Investing (Quarterly) Benchmarks
| Ocugen Inc | -0.513M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | -0.0049M |
| iBio Inc | -0.144M |
| Theriva Biologics Inc | -0.001M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -41.79M |
| Cash from Financing (Quarterly) | 3.371M |
| Free Cash Flow | -248.01M |
| Free Cash Flow Per Share (Quarterly) | -0.7287 |
| Free Cash Flow to Equity (Quarterly) | -54.02M |
| Free Cash Flow Yield | -9.78% |